Core Viewpoint - Morgan Stanley reports that UBTECH (09880) stands out in the rapidly evolving Chinese humanoid robotics industry, becoming a high-growth company, but has conducted six rounds of placements since its IPO, which may raise investor concerns and controversies, while maintaining an "Overweight" rating [1] Group 1: Company Performance - Frequent fundraising may reflect the capital intensity and competitive landscape of the industry [1] - The company is expected to secure three major government-led orders in November, which will drive revenue guidance up to a high single-digit growth [1] Group 2: Market Positioning - Inclusion in the MSCI China Index is anticipated to further enhance liquidity and market visibility [1] - Positive factors related to the company's performance are likely to continue attracting investor attention [1]
小摩：维持优必选“增持”评级 预期11月取得三份政府主导的重大订单